Rockwell Medical Technologies Closes $20 Million Debt Financing

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Rockwell Medical Receives $20 Million in New Financing

WIXOM, MI--(Marketwired - June 18, 2013) - Rockwell Medical (NASDAQ:

BIOCRATES Life Sciences GmbH Names New CEO

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Wulf Fischer-Knuppertz Appointed New CEO of BIOCRATES Life Sciences AG

INNSBRUCK, Austria , June 18, 2013 /CNW/ - On 1 June 2013 , Dr Wulf Fischer-Knuppertz, took over...

Santarus Inc. and Pharming Group Announce FDA Acceptance for Review of RUCONEST (Recombinant Human C1 Esterase Inhibitor) Biologics License Application

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, CA and LEIDEN, THE NETHERLANDS--(Marketwired - June 18, 2013) - Santarus, Inc.(NASDAQ: SNTS) and...

Immune Response BioPharma to Seek Approval of REMUNE With of South Africa

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PRLog (Press Release) - Jun. 17, 2013 - NEW YORK -- Immune Response BioPharma, Inc., has notified the Dept of Health & MCC of the Republic of South Africa that IRBP will Seek Emergency Approval of REMUNE in...

IntelGenx Corp. Announces FDA Acceptance of New Drug Application for Anti-Migraine VersaFilm™ Oral Film Product

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAINT LAURENT, Quebec, June 18, 2013 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx," or the "Company") today announced that the U.S. Food and Drug Administration ("FDA") has assigned...

RedHill Biopharma Ltd. Announces FDA Acceptance for Review of RHB-103 NDA for Acute Migraine and PDUFA Goal Date of February 3, 2014

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TEL-AVIV, Israel, June 18, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development...

Hyperion Therapeutics Announces RAVICTI and BUPHENYL Pharmacokinetic Analyses Reported in /i>

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., June 18, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that population pharmacokinetic (PK) modeling and dosing simulations were reported in...

Vanda Pharmaceuticals, Inc. Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm in Blind Patients With Non-24-Hour Disorder

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON, June 17, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) presented additional data...

Ipsen Release: "PRIMARYS" Study Investigators Observed Clinically Relevant Results in an Investigational Phase III Study With Somatuline® Autogel® 120 mg in Patients With Acromegaly

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--Ipsen (Euronext: IPN; ADR: IPSEY) today announced the results of an international phase IIIB study, PRIMARYS, assessing an investigational use of Somatuline Autogel (lanreotide) 1...

Adamas Pharmaceuticals Presents Positive Phase 2/3 Results for ADS-5102 for the Treatment of Levodopa-Induced Dyskinesia (LID) in Parkinson's Disease

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SYDNEY, Australia And EMERYVILLE, Calif., June 18, 2013 /PRNewswire/ -- Adamas...

OncoSec Medical Inc. Announces Completion of Enrollment of Phase II Metastatic Melanoma Trial

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced the completion...

TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TAIPEI, Taiwan, June 17, 2013 /PRNewswire/ -- TWi Biotechnology, Inc. today announced that it has completed...

MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Initiates Phase II Clinical Trial of Pracinostat and Vidaza® in Frontline Myelodysplastic Syndrome

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, June 18, 2013 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical...

iCo Therapeutics Inc. Announces Completion of Trial Enrollment and Clinical Update for iDEAL Phase 2 Study for the Treatment of Diabetic Macular Edema

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, June 18, 2013 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V...

DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HOUSTON, June 17, 2013 /PRNewswire/ -- DNAtrix Inc., experts in oncolytic virus development, today announced that...

PhaseBio Pharmaceuticals, Inc. Expands Clinical Development of Vasomera, an Investigational Treatment for Cardiopulmonary Diseases

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MALVERN, Pa.--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, a clinical-stage biopharmaceutical company focused on diabetes and cardiovascular diseases, today announced the successful completion of a Phase 1 trial...

Vaxil Reports Promising Results From Its Follow-Up Clinical Trial of ImMucin in Multiple Myeloma a Patients

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ness Ziona, 18th June 2013. Vaxil Bio (TASE: VAXL) which is developing therapeutic vaccinesto treat cancer and infectious diseases, reports promising results that were observed in itsfollow-up study VAXIL...

Sanford-Burnham Medical Research Institute Researchers Develop Novel Drug That Reverses Loss of Brain Connections in Models of Alzheimer's

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LA JOLLA, Calif., June 17, 2013 The first experimental drug to boost brain synapses lost in Alzheimers disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called...

New Study Shows Improvements in Public Perceptions of Clinical Research and Insights Into Participant Experiences

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON, June 18, 2013 /PRNewswire-USNewswire/ -- A new study by the Center for Information & Study on Clinical...

Halifax Teams With Management to Acquire Envision Pharma, Inc.

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON--(BUSINESS WIRE)--The Halifax Group ("Halifax"), a leading middle-market private equity firm, announced today that it has acquired Envision Pharma, Inc. ("Envision") from a subsidiary of Express Scripts...

CollabRx, Inc. to Collaborate With the on Clinical Cancer Sequencing and Interpretation

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO, June 18, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a collaboration with...

Verdezyne, Inc. Collaborates With Malaysian Biotechnology Corporation to Ensure Opportunities in Asia

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MONTREAL--(BUSINESS WIRE)--Carlsbad-based biochemical company Verdezyne, Inc. has entered into a collaboration with Malaysian Biotechnology Corporation (BiotechCorp) in its assessment of Malaysia as the destination...

Moffitt Cancer Center Announces Strategic Partnership With Advinus Therapeutics (P) Ltd.

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TAMPA, Fla. and BANGALORE, India, June 18, 2013 /PRNewswire/ --

BoXin LaiTe Biotechnology and University of British Columbia Sign MOU

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 18, 2013 -- Sichuan BoXin LaiTe Biotechnology and its major shareholder, Heracles International Investment Inc. have signed a memorandum of understanding to form a partnership...

Isotechnika Pharma Inc. Receives Additional Funding From the for the Preclinical Development of NICAM 440-02 as an Anti-Hepatitis C Agent

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EDMONTON, Alberta, June 18, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") today announced that it has received additional funding from the National Research Council...

Civitas Therapeutics Receives Second Grant for Their Lead Product CVT-301 From The Michael J. Fox Foundation for Parkinson???s Research

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CHELSEA, Mass.--(BUSINESS WIRE)--Civitas Therapeutics, Inc., a biopharmaceutical company developing transformative therapeutics using the ARCUS(TM) respiratory delivery platform, today announced it has been...

Bristol-Myers Squibb Company Grants Help K-12 Educators Bring Science to Life and Help Students Explore Their Interests in the Sciences and Science-Based Careers

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced more than $500,000 in new grants to more than a dozen educational institutions and organizations working to enhance...

US WorldMeds, LLC Receives $15 Million Grant to Launch New Study

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LOUISVILLE, Ky.--(BUSINESS WIRE)--US WorldMeds has begun enrolling patients in a Phase III clinical trial that will complete the development program for lofexidine hydrochloride (Lofexidine) as a new therapeutic...

Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol"

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NESS ZIONA, Israel, June 18, 2013 -- /PRNewswire/ --

Mapi Pharma Ltd. (Mapi), developer of complex bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished...

Repros Therapeutics Inc. Announces Proposed Public Offering of Common Stock

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

THE WOODLANDS, Texas, June 17, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (Nasdaq:RPRX) today announced that it has commenced an underwritten public offering of up to 3,000,000 shares of its common stock...

Vertex Pharmaceuticals (MA) Completes Redemption of Convertible Senior Subordinated Notes

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has completed its previously announced call for redemption of $400 million in aggregate principal...

Agilent Technologies Inc. Announces Offering of Senior Notes

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it is offering, subject to market and other conditions, a series of senior notes.

Help employers find you...

Cellectis Combined General Shareholders??? Meeting of June 14, 2013

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Alternext: ALCLS) held its Combined General Shareholders Meeting on Friday, June 14, 2013 in Paris, at the Groups headquarters.

Help employers...

BioRestorative Therapies, Inc. CEO Interviewed on "Next Big Thing" With Financial Personality and Founder

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

JUPITER, Fla., June 17, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB...

Precyse Receives HFMA Peer Reviewed Designation

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WAYNE, Pa., and ALPHARETTA, Ga., June 17, 2013 /PRNewswire/ --

Cedars-Sinai Medical Center Recovers More Than $300 million in AR with Hyland Software's OnBase

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CLEVELAND, June 17, 2013 /PRNewswire/ -- Cedars-Sinai Medical Center, ranked one of the best healthcare organizations...

Immunicum Receive Extended SME-Status From the European Medicines Agency

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Gothenburg, 2013-06-18 10:50 CEST (GLOBE NEWSWIRE) -- Immunicum AB (publ), a Swedish listed company developing therapeutic cancer vaccines, today received prolonged SME-status from the European Medicines Agency...

Prothena Shares to Be Added to Russell Global Index

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, Ireland, June 17, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential...

Monsanto Company's Drought Tolerance Trait in Genuity® DroughtGard® Hybrids Receives Final Major Import Approval From China

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ST. LOUIS, June 17, 2013 /PRNewswire/ -- China, a major importer of U.S. corn grain...

Generex Biotechnology Corporation Announces $1,225,000 Capital Investment

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WORCESTER, Mass. and TORONTO, June 17, 2013 /PRNewswire/ -- Generex Biotechnology...

Valeant Pharmaceuticals International Announces Public Offering of Common Shares

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAVAL, Quebec, June 17, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX...

FORMA Therapeutics, Inc. Launches New Collaborative Framework to Transform Basic Research Into Promising Therapies

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics announced today its Asset Discovery and Development Company (ADDCo) platform, an initiative in which FORMA will join forces with select academic, not...

Nuvo Research Inc. and Paladin Labs Inc. Announce Amendment to May 2012 Loan Arrangement

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MISSISSAUGA, ON and MONTREAL, QC, June 17, 2013 /PRNewswire/ - Nuvo Research Inc...

Roche Demonstrates Strong Commitment to Neurodevelopmental Disorders

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Basel, 18 June 2013 -- Recently, Roche hosted a scientific symposium in Basel, Switzerland, which brought together international experts to discuss new findings in neurodevelopmental disorders such as autism...

Sigma-Tau Group : A New Efficient and Cost Effective Dialysis for Patients With End Stage Renal Disease

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROME--(BUSINESS WIRE)--Thule Therapeutics S.A., an R&D Company of the Sigma-Tau Group, and Corequest Sagl announce extremely valuable findings on the use of L-Carnitine in peritoneal dialysis solutions opening...

Regulatory Affairs Professionals Society Opens Offices in Singapore and China

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Rockville, MD, USAThe Regulatory Affairs Professionals Society (RAPS) today announced the opening of two new offices in Asiaone in Singapore and one in Shanghai, China. The office in Singapore will serve as...

ADMA Biologics, Inc.???s Plasma Collection Facility Receives GHA Certification for the Sale of Source Plasma in Europe

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain...

Lab7 Systems Invites Early Access Users

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AUSTIN, TX June 18, 2013 Lab7 Systems, Inc., has announced the first beta release of its next-generation DNA sequencing (NGS) data workflow management software platform. The comprehensive sample-to-answer...

SAW Instruments GmbH Enhances Protein Interaction Analysis With the Sam®X Acoustic Biosensor

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Bonn, Germany 18 June 2013 SAW Instruments, developer of the innovative sam family of biosensors for real-time, label-free biomolecular interaction assays, is continuing to advance acoustic wave biosensor...

The Releases HELM Biomolecular Representation Standard Open Source Tools

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Wilmington, DE, June 18, 2013 - The Pistoia Alliance is pleased to announce the release of the HELM biomolecular representation standard software toolkit and editor under the permissive open source MIT licence...

Laboratory Corporation of America Holdings (LabCorp) Announces Availability of Newly Approved Viral Load Assay for Hepatitis C Virus

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) today announced that it is offering the COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0. With enhanced sensitivity...

Gram Scale Transient Antibody Production in CHO Cells With MaxCyte, Inc. Electroporation

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, is hosting an educational webinar entitled Large Scale, CHO Transient Transfection...

Pall Corporation Filters Ease Concerns about Viruses in Aircraft Cabin Air

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--The environment in airplane cabins becomes a public concern whenever a new or re-emerging pathogen, such as the MERS coronavirus or the Influenza A (H7N9) virus, is in...

New Torrey Pines Scientific, Inc. Compact Heating Dry Bath is Designed for Robots & Other Remote Controlled Systems

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Carlsbad, CA ...Torrey Pines Scientific announces its EchoTherm RHB20 compact, Heating Dry Baths with temperatures settable from ambient to 120.0C.

These units are designed for remote controlled...

Helix Biopharma Announces Q3 Fiscal 2013 Results

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AURORA, ON--(Marketwired - June 18, 2013) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical...

KaloBios Pharmaceuticals, Inc. Appoints as Chief Legal Officer

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO, June 17, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the appointment...

Susan G. Komen for the Cure Names as New CEO

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The Susan G. Komen Board of Directors has named Judith A. Salerno president and CEO of the Dallas-based nonprofit. Salerno, a medical doctor, is the executive director and chief operating officer of the Institute...

Arthur J. Tipton, Ph.D. Appointed New CEO at Southern Research Institute

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO

BIRMINGHAM, Ala., June 17, 2013 /PRNewswire-USNewswire...

Thomas A. Shea Joins EPIRUS Biopharmaceuticals as Chief Financial Officer

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (EPIRUS), a privately held biotechnology company focused on the development and production of biosimilar products in and for major emerging markets, today...

CytoDyn Appoints as Chairman of the Board of Directors

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PORTLAND, Ore.--(BUSINESS WIRE)--CytoDyn Inc. (CytoDyn) (OTC QB: CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced...

Cerebain Biotech Appoints Chairman of Its Scientific Advisory Board

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (Cerebain or the Company), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO) announced today the appointment of Dr. Surinder Saini as Chairman...

Eli Lilly and Company Diabetes, Kick off Summer With 9th Annual Diabetes Summer Camp Tour

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

INDIANAPOLIS, June 17, 2013 /PRNewswire/ --

News Highlights

#T1DiabetesChamp

BioForward (WI) Continues Wisconsin Outreach

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MADISON, Wis.--(BUSINESS WIRE)--Wisconsin biotech advocacy organization, BioForward, has announced that its 2013 Bioscience Vision Summit, scheduled for September 18, 2013 at the Monona Terrace Convention Center...

Prolacta Bioscience Announces Donor Breast Milk Supply Program for Preemies in Hospital Neonatal Intensive Care Units

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

INDUSTRY, Calif.--(BUSINESS WIRE)--Prolacta Bioscience has announced a donor breast milk supply partnership program that will ensure a safe, standardized, and guaranteed supply of 100% human breast milk products...

Bayer Corporation to Mark 150th Anniversary With Local and Global Celebrations

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PITTSBURGH--(BUSINESS WIRE)--Bayer will celebrate the 150th anniversary of its founding this year across the globe, as well as here in the United States. The companys achievements will be celebrated through...

Mayor Leads Ribbon Cutting of Emergent BioSolutions New Administration Building Representing Another Step in Its Lansing Campus Expansion

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROCKVILLE, Md.--(BUSINESS WIRE)--Lansing, Michigan Mayor Virg Bernero and senior executives from Emergent BioSolutions Inc. (NYSE:EBS) today held a ribbon cutting ceremony to commemorate the formal opening of...

BIOTECHNICA Release - BioServices: Marketplace for Service Providers in the Pharmaceuticals and Biotech Industry

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Hannover, Germany. The BioServices Marketplace is one of four new marketplace-style displays at BIOTECHNICA 2013. It is a central gathering point where representatives of pharmaceuticals and biotech companies...

Sustainable Drug Production Through Biotechnology: and Present Cutting-Edge Projects

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Berlin/Hannover, Germany Effective medications, resource savings, efficient production and low emissions: at Biotechnica 2013, DBU demonstrates how to achieve all these core goals for sustainable pharmaceutical...

National Institutes of Health (NIH) to Fund Collaborations With Industry to Identify New Uses for Existing Compounds

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease...

BIOTECHNICA: The German Biotech Sector: Status Quo and the Latest Trends

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Berlin/Hannover. There are many ways to assess the condition of a business sector. The number of companies and employees, revenues and investments are all important indicators for evaluating how the German biotech...

BIOTECHNICA 2013: Spotlight on the Food Industry

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Hannover, Germany. The Innovation in Food Marketplace is a new addition to the BIOTECHNICA shows food biotechnology lineup. It takes a comprehensive look at the role of biotechnology in the production of safe...

Medivation, Inc. Voted Among Top Workplaces in the SF Bay Area

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO, CA--(Marketwired - June 18, 2013) - Medivation, Inc...

Quintiles, Inc. Named a ???Best Place to Work in IT??? by /i> for Fifth Time

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles (NYSE: Q) has been named to IDGs Computerworld 100 Best Places to Work in IT list for the fifth time.

Computerworld has recognized the top...

Prime Therapeutics Receives Prestigious Silver Anvil Award From Public Relations Society of America

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ST. PAUL, Minn., June 17, 2013 /PRNewswire/ -- Prime Therapeutics, in collaboration with public relations agency...

Centene Corporation to Present at 2013 Healthcare Conference

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ST. LOUIS, June 17, 2013 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at...

Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MUNDELEIN, Ill., June 17, 2013 /PRNewswire/ -- Z Trim Holdings, Inc. (OTC Markets: ZTHO News), a biotechnology company...

VistaGen Therapeutics, Inc. Presents CardioSafe 3D™ and LiverSafe 3D™ Developments at International Society for Stem Cell Research's 11th Annual Meeting

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, CA--(Marketwired - June 17, 2013) - VistaGen Therapeutics, Inc. (OTCQB: VSTA), a biotechnology...

Lightlake Therapeutics Inc. to Present at 4th Annual

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LONDON--(BUSINESS WIRE)--Lightlake Therapeutics Inc. (OTCBB: LLTP) (the Company, We or Lightlake), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists...

ACADIA Pharmaceuticals, Inc. Announces Multiple Presentations of Data from Phase III Pimavanserin Program at the

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous...

Gilead Sciences, Inc. to Present at the Healthcare Conference on Tuesday, June 18

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Wells Fargo Securities 2013 Healthcare Conference in Boston...

BIOTECHNICA 2013 ??? Europe's Biotech Hub

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Hannover, Germany. Featuring new topics and innovative marketplaces, BIOTECHNICA 2013 in Hannover will for three days (from 8 to 10 October) once again serve as the central hub for Europes entire biotech sector...

Industrial Biotechnology Demonstrates Its Vast Potential at BIOTECHNICA 2013

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Hannover, Germany. The industrial biotechnology sector has firmly established itself as a powerhouse of innovation for the real world. Biological systems are already employed in the sustainable manufacture of...

Switzerland to be Showcased as BIOTECHNICA Partner Country in 2013

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Hannover/Zurich. Switzerland will be the official Partner Country of BIOTECHNICA 2013. The Partner Country arrangement, the first ever for BIOTECHNICA, was announced recently by representatives of Deutsche Messe...

Purdue Pharma L.P. to Present Data Describing Changes in Oxycodone Abuse in Rural Kentucky Following the Introduction of Reformulated Oxycontin ® (Oxycodone HCl Controlled-Release) at the

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, June 17, 2013 Purdue Pharma L.P. will present a poster describing the changes in abuse of OxyContin and immediate-release oxycodone in rural Kentucky following the August 2010 introduction of reformulated...

Merck & Co., Inc. to Cut Research Jobs as Sets Direction

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Merck & Co. (MRK), the second-largest U.S. drugmaker, plans to cut jobs at its research laboratories, two months after Roger Perlmutter took helm of the unit. The shakeup includes immediate elimination of some...

Johnson & Johnson to Buy Aragon Pharmaceuticals, Inc. for Up to $1 Billion

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Aragon Pharmaceuticals Announces Acquisition by Johnson & Johnson

SAN DIEGO, CA--(Marketwired - June 17, 2013) - Aragon Pharmaceuticals...

Changes Happening Inside Merck & Co., Inc.'s R&D

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

I've heard from more than one source that Roger Perlmutter has been shaking things up this week at Merck. Since he only took over R&D in March, that's a pretty short lag time - if these reports are accurate...

Norbrook Laboratories Launch Major Recruitment Drive for 400 New Jobs

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Norbrook is a leading manufacturer of veterinary pharmaceuticals and contract manufactures for all of the top pharmaceutical companies in the world at its three plants in Newry. In recent years the company has...

AstraZeneca PLC and NGM Biopharmaceuticals, Inc. Form Diabetes/Obesity Partnership

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AstraZeneca: MedImmune, AstraZenecas Biologics Arm, and NGM Biopharmaceuticals Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity

SDERTLJE...

Novo Nordisk A/S Drops as New Eli Lilly and Company Drug Threatens Victoza

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Novo Nordisk A/S (NOVOB) fell the most among benchmark stocks in Copenhagen trading after Bank of America Merrill Lynch said the diabetes drug companys Victoza medicine faces a real threat from an Eli Lilly...

Teva Pharmaceutical Industries Limited Bags MicroDose Therapeutx (formerly MicroDose Technologies Inc) for $165 Million

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Teva Strengthens Respiratory Franchise with Acquisition of MicroDose Therapeutx

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (TEVA) today announced...

What Eli Lilly and Company's Cut Alzheimer's Drug Means for Merck & Co., Inc.

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Once again, Eli Lilly has suffered a setback trying to find a useful drug to combat Alzheimers. Last year, a pair of late-stage trials for an injectable drug called solanezumab failed to meet primary endpoints...

Perrigo Company Buys Fera Pharmaceuticals's Ophthalmic Product Portfolio for up to $129 Million

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million

Positive Survival Data for Bristol-Myers Squibb Company/AbbVie's Blood Cancer Drug

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of Investigational Agent Elotuzumab in Combination with Lenalidimide and Dexamethasone...

Safety Fears Force Eli Lilly and Company to Halt Alzheimer's Trial

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimer's Disease

INDIANAPOLIS, ...

Sanofi (France)'s Animal Health Arm Seals Deal With

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The domestic animal health market just got more competitive, with one more multinational player -- drug-maker Sanofis animal health division Merial, sealing a deal in this segment. Merial had formalised an...

AOP Orphan Pharmaceuticals AG Spins Off Its Stake in Activartis Biotech GmbH and Outlines Business Strategy

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Vienna, Austria, June 17, 2013 / B3C newswire / - AOP Orphan Pharmaceuticals AG today announced the spin off of its 80 % stake in Activartis GmbH, a Vienna-based biotech company with a strong platform for immune...

Transition Therapeutics Inc. to Get $7 Million as Eli Lilly and Company to Assume Rights to TT-401

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Transition Therapeutics Announces Exercise of TT-401 Rights by Lilly

TORONTO, June 17, 2013 /PRNewswire/ - Transition Therapeutics...

These Mutated Cystic Fibrosis Cells are Worth Billions to Vertex Pharmaceuticals (MA)

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

This is my favorite data slide from Vertex Pharmaceuticals' (VRTX_) presentation at the European Cystic Fibrosis Society meeting. The slide is important because it helps explain how Vertex will dominate cystic...

Repeat Offender: Baxter BioScience Corporation, the FDA and Too Much Mold to Count

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

As the FDA continues its push to crack down on manufacturing violations, warning letters have become standard fare. But every so often, a missive stands out from the crowd thanks to the sort of violations that...

Workers of Puducherry Facility on Strike

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Drug firm Shasun Pharmaceuticals today said operations at its Puducherry facility have been affected due to strike by workers. A strike was resorted by the workers at the company's Puducherry facility that manufactures...

Janssen Research & Development's Ibrutinib Monotherapy Shows Efficacy in Patients With MCL or DLBCL

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma

RARITAN...

Royalty Pharma Hostile Bid for Elan Corporation PLC in Doubt After Vote

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Elan Announces Results of EGM

DUBLIN--(BUSINESS WIRE)--Jun. 17, 2013-- Elan Corporation, plc (NYSE:ELN) (Elan or the Company) announces that, at its Extraordinary General...

Cell Therapeutics, Inc. Release: New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, June 17, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced results...

Orexo AB Release: First Patient Dosed in New Phase III Study Targeted Towards a Future Clinical Indication Expansion for Zubsolv

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Uppsala, Sweden June 17, 2013 - Orexo AB announces today that the firstpatient has been dosed with Zubsolv in a phase III study for a new clinicalindication for Zubsolv.

Help employers find...

NPS Pharmaceuticals, Inc. Release: Initial Findings from PARADOX, Largest and Most Comprehensive Research Analyzing the Burden of Hypoparathyroidism, Reveals Collection of Nearly 40 Physical, Cognitive, Emotional Symptoms

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide...

Orexo AB: First Patient Dosed in New Phase III Study Targeted Towards a Future Clinical Indication Expansion for Zubsolv

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB (STO:ORX) announces today that the first patient has been dosed with Zubsolv in a phase III study for a new clinical indication for Zubsolv. Currently...

MannKind Corporation Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 Diabetes

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today announced that all follow-up visits have been completed for the patients enrolled in Study 175, a Phase 3 clinical study of AFREZZA...

Incyte Corporation Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients With Myelofibrosis

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STOCKHOLM--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced results from two ongoing clinical trials of Jakafi (ruxolitinib), an oral JAK1 and JAK2 inhibitor that is FDA-approved for the treatment...

Gilead Sciences, Inc. Announces Interim Phase 2 Data for Idelalisib Showing Response in Refractory Indolent Non-Hodgkin's Lymphoma

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LUGANO, Switzerland--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced interim results from a single-arm, open-label Phase 2 study (Study 101-09) evaluating idelalisib (formerly GS-1101...

Cell Therapeutics, Inc. Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients With Myelofibrosis

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, June 17, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced...

Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY-1215 for the Treatment of Multiple Myeloma

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--Acetylon Pharmaceuticals Inc., the leader in development of selective histone deacetylase (HDAC) inhibitors for enhanced therapeutic outcomes, today announced the presentation of clinical...

NPS Pharmaceuticals, Inc. Release: Findings Presented at Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients With Hypoparathyroidism

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide...

Versartis, Inc. Presents Positive Results From Its First Pediatric Clinical Study of Novel Long-Acting Growth Hormone Treatment at

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO, CA--(Marketwired - June 16, 2013) -
Highlighted Links

Array BioPharma, Inc. Announces Positive Interim Results From Combination Trial of ARRY-520 With Kyprolis at the 2013 European

Mon, 17 Jun 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOULDER, Colo., June 17, 2013/PRNewswire...

BioSpace.com Featured News

AstraZeneca PLC Announces New $500 Million Cambridge Biomedical Campus HQ, Will Employ 2000 by 2016

Alexion Pharmaceuticals Inc. to Break Ground on $100 Million Headquarters, Will Create 200-300 New Jobs

Niche Drugmaker ViroPharma Incorporated Attracts Takeover Interest -Sources

FDA Probes Deaths of Two Patients on Eli Lilly and Company Schizophrenia Drug

New Chief Faces Questions and Uncertainties, Acknowledges Takeda Pharmaceutical Co. Ltd. Restructuring May Lead to Job Cuts

Onconova Therapeutics Inc. Files for $75 Million IPO

Success With an Angel Syndicate: How One Pharma Startup, Savara, Raised $16 Million Without VCs

Amicus Therapeutics, Inc. Shelves New-Drug Filing for Fabry Disease Drug

Royalty Pharma Drops Hostile Bid for Elan Corporation PLC

Roche's Avastin Approved in Japan for Treatment of Aggressive Brain Cancer

Rockwell Medical Technologies Closes $20 Million Debt Financing

BIOCRATES Life Sciences GmbH Names New CEO

Santarus Inc. and Pharming Group Announce FDA Acceptance for Review of RUCONEST (Recombinant Human C1 Esterase Inhibitor) Biologics License Application

Immune Response BioPharma to Seek Approval of REMUNE With of South Africa

IntelGenx Corp. Announces FDA Acceptance of New Drug Application for Anti-Migraine VersaFilm™ Oral Film Product

RedHill Biopharma Ltd. Announces FDA Acceptance for Review of RHB-103 NDA for Acute Migraine and PDUFA Goal Date of February 3, 2014

Hyperion Therapeutics Announces RAVICTI and BUPHENYL Pharmacokinetic Analyses Reported in /i>

Vanda Pharmaceuticals, Inc. Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm in Blind Patients With Non-24-Hour Disorder

Ipsen Release: "PRIMARYS" Study Investigators Observed Clinically Relevant Results in an Investigational Phase III Study With Somatuline® Autogel® 120 mg in Patients With Acromegaly

Adamas Pharmaceuticals Presents Positive Phase 2/3 Results for ADS-5102 for the Treatment of Levodopa-Induced Dyskinesia (LID) in Parkinson's Disease

OncoSec Medical Inc. Announces Completion of Enrollment of Phase II Metastatic Melanoma Trial

TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201

MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Initiates Phase II Clinical Trial of Pracinostat and Vidaza® in Frontline Myelodysplastic Syndrome

iCo Therapeutics Inc. Announces Completion of Trial Enrollment and Clinical Update for iDEAL Phase 2 Study for the Treatment of Diabetic Macular Edema

DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus

PhaseBio Pharmaceuticals, Inc. Expands Clinical Development of Vasomera, an Investigational Treatment for Cardiopulmonary Diseases

Vaxil Reports Promising Results From Its Follow-Up Clinical Trial of ImMucin in Multiple Myeloma a Patients

Sanford-Burnham Medical Research Institute Researchers Develop Novel Drug That Reverses Loss of Brain Connections in Models of Alzheimer's

New Study Shows Improvements in Public Perceptions of Clinical Research and Insights Into Participant Experiences

Halifax Teams With Management to Acquire Envision Pharma, Inc.

CollabRx, Inc. to Collaborate With the on Clinical Cancer Sequencing and Interpretation

Verdezyne, Inc. Collaborates With Malaysian Biotechnology Corporation to Ensure Opportunities in Asia

Moffitt Cancer Center Announces Strategic Partnership With Advinus Therapeutics (P) Ltd.

BoXin LaiTe Biotechnology and University of British Columbia Sign MOU

Isotechnika Pharma Inc. Receives Additional Funding From the for the Preclinical Development of NICAM 440-02 as an Anti-Hepatitis C Agent

Civitas Therapeutics Receives Second Grant for Their Lead Product CVT-301 From The Michael J. Fox Foundation for Parkinson???s Research

Bristol-Myers Squibb Company Grants Help K-12 Educators Bring Science to Life and Help Students Explore Their Interests in the Sciences and Science-Based Careers

US WorldMeds, LLC Receives $15 Million Grant to Launch New Study

Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol"

Repros Therapeutics Inc. Announces Proposed Public Offering of Common Stock

Vertex Pharmaceuticals (MA) Completes Redemption of Convertible Senior Subordinated Notes

Agilent Technologies Inc. Announces Offering of Senior Notes

Cellectis Combined General Shareholders??? Meeting of June 14, 2013

BioRestorative Therapies, Inc. CEO Interviewed on "Next Big Thing" With Financial Personality and Founder

Precyse Receives HFMA Peer Reviewed Designation

Cedars-Sinai Medical Center Recovers More Than $300 million in AR with Hyland Software's OnBase

Immunicum Receive Extended SME-Status From the European Medicines Agency

Prothena Shares to Be Added to Russell Global Index

Monsanto Company's Drought Tolerance Trait in Genuity® DroughtGard® Hybrids Receives Final Major Import Approval From China

Generex Biotechnology Corporation Announces $1,225,000 Capital Investment

Valeant Pharmaceuticals International Announces Public Offering of Common Shares

FORMA Therapeutics, Inc. Launches New Collaborative Framework to Transform Basic Research Into Promising Therapies

Nuvo Research Inc. and Paladin Labs Inc. Announce Amendment to May 2012 Loan Arrangement

Roche Demonstrates Strong Commitment to Neurodevelopmental Disorders

Sigma-Tau Group : A New Efficient and Cost Effective Dialysis for Patients With End Stage Renal Disease

Regulatory Affairs Professionals Society Opens Offices in Singapore and China

ADMA Biologics, Inc.???s Plasma Collection Facility Receives GHA Certification for the Sale of Source Plasma in Europe

Lab7 Systems Invites Early Access Users

SAW Instruments GmbH Enhances Protein Interaction Analysis With the Sam®X Acoustic Biosensor

The Releases HELM Biomolecular Representation Standard Open Source Tools

Laboratory Corporation of America Holdings (LabCorp) Announces Availability of Newly Approved Viral Load Assay for Hepatitis C Virus

Gram Scale Transient Antibody Production in CHO Cells With MaxCyte, Inc. Electroporation

Pall Corporation Filters Ease Concerns about Viruses in Aircraft Cabin Air

New Torrey Pines Scientific, Inc. Compact Heating Dry Bath is Designed for Robots & Other Remote Controlled Systems

Helix Biopharma Announces Q3 Fiscal 2013 Results

KaloBios Pharmaceuticals, Inc. Appoints as Chief Legal Officer

Susan G. Komen for the Cure Names as New CEO

Arthur J. Tipton, Ph.D. Appointed New CEO at Southern Research Institute

Thomas A. Shea Joins EPIRUS Biopharmaceuticals as Chief Financial Officer

CytoDyn Appoints as Chairman of the Board of Directors

Cerebain Biotech Appoints Chairman of Its Scientific Advisory Board

Eli Lilly and Company Diabetes, Kick off Summer With 9th Annual Diabetes Summer Camp Tour

BioForward (WI) Continues Wisconsin Outreach

Prolacta Bioscience Announces Donor Breast Milk Supply Program for Preemies in Hospital Neonatal Intensive Care Units

Bayer Corporation to Mark 150th Anniversary With Local and Global Celebrations

Mayor Leads Ribbon Cutting of Emergent BioSolutions New Administration Building Representing Another Step in Its Lansing Campus Expansion

BIOTECHNICA Release - BioServices: Marketplace for Service Providers in the Pharmaceuticals and Biotech Industry

Sustainable Drug Production Through Biotechnology: and Present Cutting-Edge Projects

National Institutes of Health (NIH) to Fund Collaborations With Industry to Identify New Uses for Existing Compounds